The World Health Organization (WHO) has granted authorization for a second malaria vaccine, which could potentially offer countries a cost-e potent alternative, to the initial vaccine for this parasitic disease. Developed through a collaboration between Oxford University and the Serum Institute of India this new vaccine requires three doses. Has been given the light by WHO Director-General Tedros Adhanom Ghebreyesus. It is recommended for use in children who are at risk of malaria.
Tedros expressed his excitement about reaching this milestone saying, “As someone who has researched malaria I always dreamed of having an effective vaccine against it. Now we have two.” Research suggests that this vaccine is over 75% effective and can provide protection for one year with a booster shot. Additionally, it is estimated to cost between $2 to $4 per dose making it an affordable option for countries. It is expected to become available in selected nations next year.
This year regulatory authorities in Ghana and Burkina Faso had already approved the use of this vaccine. However experts like John Johnson, from Doctors Without Borders caution against expecting that this vaccine alone will completely eradicate malaria.
Johnson stresses that although the new malaria vaccine is a tool, in combating the disease it should not be seen as a substitute for preventive measures like using bed nets and spraying insecticides.
To sum up, the authorization of this malaria vaccine marks an advancement in the fight, against a long-standing and persistent illness.